Navigation Links
DURECT in Medical News

Endo Pharmaceuticals Returns Product Rights to TRANSDUR(TM)-Sufentanil to DURECT

CUPERTINO, Calif., Feb. 27 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX ) today reported that Endo Pharmaceuticals (Nasdaq: ENDP ) has given notice that it is returning to us Endo's rights in the U.S. and Canada to develop and commercialize TRANSDUR(TM)-Sufentanil, a propriet...

DURECT Corporation Announces Second Quarter 2009 Financial

...UPERTINO, Calif., Aug. 3 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) announced today fina.../prnh/20020717/DRRXLOGO ) At June 30, 2009, durect had cash and investments of $41.9 million, compare...(TM) (SABER(TM)-Bupivacaine). During the quarter, durect continued enrollment in our approximately 6...

DURECT to Present at the BMO Capital Markets Healthcare Conference

...PERTINO, Calif., July 28 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) announced today that...com/cgi-bin/prnh/20020717/DRRXLOGO ) About durect Corporation durect is an emerging specialty pharmaceutical company de...

DURECT Corporation Invites You to Join Its Second Quarter 2009 Earnings Conference Call

... 27 /PRNewswire-FirstCall/ -- In conjunction with durect Corporation's (Nasdaq: DRRX ) second quarter 200...in the "Investor Relations" section. About durect Corporation durect is an emerging specialty pharmaceutical company de...

REMOXY(R) NDA Update

...UPERTINO, Calif., July 7 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) today reported that ... Corporate Relationships In December 2002, durect licensed to Pain Therapeutics, Inc. the right to d...ied opioid compounds. Under the license agreement, durect is reimbursed for formulation and other work perfo...

DURECT Appoints Dr. Joseph Stauffer as Chief Medical Officer and Executive Vice President, Corporate Strategy

...PERTINO, Calif., June 16 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) announced today that Dr. Joseph Stauffer has joined durect as Chief Medical Officer and Executive Vice Presid...ucts," stated James E. Brown, President and CEO of durect Corporation. "We're looking forward to the impact...

DURECT Corporation Invites You to Join its First Quarter 2009 Earnings Conference Call

...l 28 /PRNewswire-FirstCall/ -- In conjunction with durect Corporation's (Nasdaq: DRRX ) first quarter 2009...n the "Investor Relations" section. About durect Corporation durect is an emerging specialty pharmaceutical company de...

DURECT to Participate in Cowen and Company Healthcare Conference

...PERTINO, Calif., March 9 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) announced today that...e in the "Investor Relations" section. About durect Corporation durect is an emerging specialty pharmaceutical company de...

Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results

...nt of oral mucositis, was on clinical hold, while EN 3270 was licensed from durect Corporation and in Phase II development for the treatment of moderate-to-severe chronic pain. Endo will return to durect all development rights to its transdermal sufentanil patch. 2009 Fina...

DURECT Corporation Invites You to Join Its Fourth Quarter 2008 Earnings Conference Call

...b. 2 /PRNewswire-FirstCall/ -- In conjunction with durect Corporation's (Nasdaq: DRRX ) fourth quarter 200...e in the "Investor Relations" section. About durect Corporation durect is an emerging specialty pharmaceutical company de...
DURECT in Medical Technology

ELADUR(TM) Development Update: DURECT Receives Orphan Drug Designation for Bupivacaine for Post-Herpetic Neuralgia

CUPERTINO, Calif., June 30 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX ) announced today that the US Food and Drug Administration (FDA) has granted to DURECT orphan drug designation for bupivacaine for relief of persistent pain associated with post-herpetic neuralgia (PHN). Bup...

DURECT Reports Positive Phase IIb Data from TRANSDU(TM)-Sufentanil Clinical Program

...ERTINO, Calif., March 16 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) announced today posi...therapy," stated James Brown, President and CEO of durect Corporation. "We believe that our small, patient-...t to partner or to progress ourselves. About durect Corporation ...

REMOXY(R) NDA Filing Accepted by FDA and Priority Review Granted

...PERTINO, Calif., Aug. 12 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) announced today that ... release dosage forms on the market today. About durect Corporation durect is an emerging specialty pharmaceutical company de...

DURECT Announces Positive ELADUR(TM) Phase IIa Study Results

...PERTINO, Calif., Dec. 18 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) announced today posit...d characteristics of analgesic activity of ELADUR. durect anticipates that detailed results will be submitte...lock, epidural and intrathecal anesthesia. About durect Corporation ...

Primary Endpoint of Pivotal Phase III Clinical Trial Achieved for Remoxy(TM)

...UPERTINO, Calif., Dec. 6 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) announced today that ...dded benefit of being less prone to abuse. About durect Corporation durect Corporation is an emerging specialty pharmaceutica...

DURECT Provides an Update to the Memryte Program Under Development by Voyager Pharmaceutical Corp

...nds among women, but no positive effect among men. durect has not independently verified the analysis perfor...eking a potential partner for the program. About durect Corporation durect Corporation is an emerging specialty pharmaceutica...
DURECT in Biological Technology

DURECT Corporation Announces Third Quarter 2008 Financial Results

...UPERTINO, Calif., Nov. 3 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) announced today finan...les based milestones. If ELADUR is commercialized, durect would also receive royalties on product sales. Alp...chive in the "Investor Relations" section. About durect Corporation ...

DURECT's Collaboration With Alpharma Clears HSR Review and Is Effective

...PERTINO, Calif., Oct. 29 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) announced today that ...arma Ireland Limited and DURECT, Alpharma has paid durect an upfront license fee of $20 million, with possib...les based milestones. If ELADUR is commercialized, durect would also receive a royalty on product sales. Alp...

New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone)

...PERTINO, Calif., June 10 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) announced today that ...er). Corporate Relationships In December 2002, durect licensed to Pain Therapeutics, Inc. the right to d...d drug candidates. In addition, if commercialized, durect will receive royalties for Remoxy and certain othe...

DURECT Corporation to Participate in Upcoming Healthcare Conferences

...UPERTINO, Calif., June 6 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) announced today that ...chive in the "Investor Relations" section. About durect Corporation durect Corporation is an emerging specialty pharmaceutica...

DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results

...UPERTINO, Calif., Feb. 5 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) announced today finan...r the same period in 2006. At December 31, 2007, durect had cash and investments of $62.0 million, compare... over existing therapeutics." Highlights for durect in Fiscal Year 2007 include: -- Remoxy. In Dece...

DURECT Corporation Invites You to Join Its Fourth Quarter 2007 Earnings Conference Call

.... 31 /PRNewswire-FirstCall/ -- In conjunction with durect Corporation's (Nasdaq: DRRX ) fourth quarter 2007...chive in the "Investor Relations" section. About durect Corporation durect Corporation is an emerging specialty pharmaceutica...

DURECT to Host Webcast in Conjunction with an Analyst's Day on October 17

...PERTINO, Calif., Oct. 16 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) announced today that ...wscom.com/cgi-bin/prnh/20020717/DRRXLOGO ) About durect Corporation durect Corporation is an emerging specialty pharmaceutica...

Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIG's Plenary Panel in Vegas

...feTech Innovations -- Maggie Pax, Senior Director, Business Development, MicroCHIPS -- Michael Arenberg, Executive Director, Business Development, durect -- Fernando Alvarez-Nunez, PhD, Principal Scientist, Small Molecule Pharmaceutics, Amgen -- Ashutosh Sharma, PhD, Executive Vice President, V...

DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference

...PERTINO, Calif., Aug. 29 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) announced today that ...rchive in the "Investor Relations" section. About durect Corporation durect Corporation is an emerging specialty pharmaceutica...
Other Tags
(Date:1/22/2015)... York, New York (PRWEB) January 22, 2015 ... http://www.vaginalmeshlawsuit2015.com/ ) in the U.S. District Court, Southern District of ... C.R. Bard, Inc. in that proceeding’s first bellwether trial. In ... request for a new trial after finding that C.R. Bard ...
(Date:1/22/2015)... 20 years, Dr. David Cruz of Cruz Chiropractic Care ... about every type of injury that can result from car accidents ... years, the team at Doctors on Liens has been ... With the combined breadth of experience between the two, ...
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy Champagne wedding ... revenues in the past three years. Today, the business announces ... According to the sales manager of the company, this is ... 2015. This point can be reflected on the discounted wedding ...
(Date:1/22/2015)... January 22, 2015 As interest in the ... care gains momentum worldwide, Rev. Eric J. Hall , ... Network (HCCN), will be the keynote speaker on January ... Israel’s public health system. , The conference, “Hope and Resilience: ...
(Date:1/22/2015)... 2015 State Forestry Institute of Mecklenburg-Vorpommern ... with support from GEOSYSTEMS, a dedicated Hexagon Geospatial and ... leverage Hexagon Geospatial’s ERDAS APOLLO for cataloging, ... as point clouds and documents. This effort will enable ...
Breaking Medicine News(10 mins):Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 3
(Date:1/22/2015)... Jan. 22, 2015   EyeLock, Inc. , a market leader ... Steve Gerber to the new role of Senior ... for leading development of mobile platforms and wearable solutions for ... and innovation in the semiconductor industry to his role at ...
(Date:12/24/2014)... , Dec. 23, 2014  Since its launch in December 2014, the ... eliminate the pain of trying to remember their usernames and ... fused to their smartphones. To assist people who have struggled ... company that created 1U and focuses on redefining identity, announced ...
(Date:12/22/2014)... , Dec. 22, 2014 Research and Markets ... of the "The Global Watermarking and Fingerprinting ... http://photos.prnewswire.com/prnh/20130307/600769 This ... media watermarking and fingerprinting markets. Watermarking aims to ...
Breaking Biology News(10 mins):EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 3The Global Watermarking and Fingerprinting Markets 2
Other Contents